Karyopharm Therapeutics Inc. Share Price
NASDAQ: KPTIHealthcare
Live Karyopharm Therapeutics Inc. Share Price Chart
O H L
Karyopharm Therapeutics Inc. Performance Overview
Days Range
▼
$1.72Low
$1.76High
Markets Today
| Previous Close | $1.79 |
|---|---|
| Open | $1.76 |
| Volume | 79,986 |
| Day's Range | $1.72 - $1.76 |
| 52W Range | $1.24 - $10.99 |
| Market Cap | $38.56 M |
Historical Performance
| 1M Returns | -7.25 |
|---|---|
| 3M Returns | -80.16 |
| 6M Returns | -78.69 |
| 1Y Returns | -68.76 |
| 5Y Returns | -98.03 |
| 10Y Returns | -98.69 |
Karyopharm Therapeutics Inc. Fundamentals
| Market Cap | $38.56 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $146.07 M |
| ROE TTM | N/A |
| EPS TTM | $-12.84 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-90.41 M |
| Profit Margin | -134.21 |
| Market Cap | $38.56 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $146.07 M |
| ROE TTM | N/A |
| EPS TTM | $-12.84 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-90.41 M |
| Profit Margin | -134.21 |
Karyopharm Therapeutics Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $30.02 M | $37.93 M | $44.04 M | $34.08 M | $35.07 M | $33.43 M |
| Gross Profit + | $28.71 M | $36.88 M | $41.93 M | $32.59 M | $33.72 M | $32.35 M |
| Operating Income | -$33.26 M | -$24.39 M | -$15.22 M | -$17.84 M | -$26.76 M | -$22.53 M |
| EBITDA | -$33.18 M | -$24.31 M | -$15.10 M | -$17.82 M | -$26.75 M | -$22.53 M |
| Interest Expense | -$10.99 M | -$11.23 M | -$11.01 M | -$12.62 M | -$12.55 M | -$13.14 M |
| Depreciation | $78.00 K | $78.00 K | $121.00 K | $19.00 K | $12.00 K | -$3.00 K |
| Income Before Tax | -$23.43 M | -$37.21 M | -$33.09 M | -$102.27 M | -$22.39 M | -$67.02 M |
| Income Tax Expense | $36.00 K | $40.00 K | $34.00 K | -$67.00 K | $1.00 K | $0 |
| Net Income + | -$23.46 M | -$37.25 M | -$33.13 M | -$102.20 M | -$22.39 M | -$67.02 M |
| Net Profit Margin | -78.17% | -98.22% | -75.21% | -299.89% | -63.86% | -200.48% |
Karyopharm Therapeutics Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $13.00 K | $13.00 K | $13.00 K | $14.00 K | $14.00 K | $14.00 K |
| Reserve & Surplus | -$1.59 B | -$1.62 B | -$1.66 B | -$1.76 B | -$1.78 B | -$1.85 B |
| Non-Current Liabilities | $243.22 M | $244.59 M | $278.33 M | $309.28 M | $279.76 M | $307.25 M |
| Current Liabilities | $90.37 M | $99.22 M | $87.16 M | $92.06 M | $117.30 M | $134.23 M |
| Total Liabilities | $333.60 M | $343.81 M | $365.49 M | $401.34 M | $397.06 M | $441.49 M |
| Fixed Assets | $322.00 K | $244.00 K | $122.00 K | $104.00 K | $91.00 K | $94.00 K |
| Current Assets | $120.24 M | $97.87 M | $89.75 M | $103.15 M | $126.33 M | $106.38 M |
| Total Assets | $127.71 M | $104.88 M | $96.23 M | $108.42 M | $131.42 M | $111.32 M |
Karyopharm Therapeutics Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$23.46 M | -$37.25 M | -$33.13 M | -$102.20 M | -$22.39 M | -$67.02 M |
| Operating Cash Flow | -$38.98 M | -$18.70 M | -$5.86 M | -$11.83 M | -$22.73 M | -$24.93 M |
| Investing Cash Flow | $15.29 M | $18.29 M | $4.80 M | $5.00 M | $3.20 M | -$10.04 M |
| Financing Cash Flow | $0 | $356.00 K | $0 | $29.69 M | $49.80 M | -$898.00 K |
| Change in Cash | -$23.69 M | -$48.00 K | -$1.05 M | $22.87 M | $30.28 M | -$35.87 M |
Karyopharm Therapeutics Inc. Return Calculator
The Karyopharm Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$187
Invested Amount$10,000
Est. Returns$-9,813
About Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
Popular Stocks
FAQs
What is the share price of Karyopharm Therapeutics Inc. today?
Karyopharm Therapeutics Inc. (KPTI) share price as of September 18, 2026 is $1.70. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Karyopharm Therapeutics Inc.?
Yes, Indian Investors can invest in the Karyopharm Therapeutics Inc. (KPTI) Share by opening an international trading account with Angel One.
How can I purchase Karyopharm Therapeutics Inc. shares in India?
Purchasing Karyopharm Therapeutics Inc. (KPTI) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Karyopharm Therapeutics Inc. (KPTI) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Karyopharm Therapeutics Inc.?
Yes, you can purchase fractional shares of Karyopharm Therapeutics Inc. (KPTI) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Karyopharm Therapeutics Inc.?
The market capitalization of Karyopharm Therapeutics Inc. on September 18, 2026, is $38.56 M.
In which sector Karyopharm Therapeutics Inc. belongs?
Karyopharm Therapeutics Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Karyopharm Therapeutics Inc. stocks?
In order to invest in Karyopharm Therapeutics Inc. (KPTI) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
